Maternal and/or fetal factors that influence Congenital Zika Syndrome (CZS) development remain elusive. Interferon lambda has been reported as an antiviral factor in Zika infections. Using functional analysis, we conducted a case-control study to demonstrate that maternal interferon lambda single nucleotide polymorphisms (SNPs) contribute to newborn protection. Mothers carrying CA/CC genotypes of rs8109886 SNP have 4.5 times reduced risk of having children with CZS. When we combined the genotypes CC from rs12979860 and CA/CC from rs8109886, 93% of the mothers delivered healthy newborns.
INTRODUCTION
Zika virus (ZIKV) is a single strand positive-sense RNA virus that belongs to the Flaviviridae family; this infection is mostly asymptomatic or associated with mild symptoms.
After the outbreak in the Americas in 2015, the virus spread across 59 countries and more than 500.000 suspected cases were reported (Relich and Loeffelholz, 2017) . In a short while, there was a rise in the cases of congenital abnormalities, including cerebral anomalies, congenital contractures, and ocular alterations besides neurological abnormalities known as Congenital Zika Syndrome (CZS) (Adhikari et al., 2017; de Araújo et al., 2018; Jürgens and Rey, 2018; Wen et al., 2017) . In a prospective cohort study, our group observed that 46% of the infants that were born to ZIKV-infected mothers bore abnormal clinical or brain imaging findings, including four infants with microcephaly, regardless of the trimester in pregnancy (Brasil et al., 2016) . Indeed, in a little while, and a case-control study confirmed the association between the infection and CZS and ZIKV epidemic was declared a public health emergence of international concern (de Araújo et al., 2018; 2017b) . Nevertheless, not all the infants that are born to ZIKV-infected mothers will develop CZS, and it is not clear what maternal and/or fetal factors contribute to infant adverse neurologic outcomes. One important risk factor for CSZ is infection within the first trimester of pregnancy, which poses almost twice as high risks of severe outcomes as CNS abnormalities when compared with the third trimester infections (Brasil et al., 2016) . It has been reported that genetic background can influence the outcome, although no targets or candidates have been identified, and it is likely that mothers' genetic factors could also be involved in CZS outcome (Caires-Júnior et al., 2018) .
During other congenital infections, namely TORCH (Toxoplasma, Others, Rubella, Cytomegalovirus, Herpes), which may cause malformations, placenta has been described as playing a crucial role in mother to fetus transmissions (Coyne and Lazear, 2016) . In ZIKV infection, one of the hypotheses for the emergence of adverse neurological outcomes is that ZIKV can infect and cross trophoblast cell layers as a cargo to reach the fetal neurologic system, causing direct damage. On the other hand, ZIKV infection would cause an immunological imbalance in the placenta, disrupting the embryonic brain development (Bayer et al., 2016; Delorme-Axford et al., 2013; Grant et al., 2016; Hirsch et al., 2018; Noronha et al., 2016; Quicke et al., 2016; Tabata et al., 2016) . This theory is aligned with other situations where microcephaly may occur, such as radiation exposure, tobacco smoke, cocaine use, alcohol consumption, cytomegalovirus, or α-hemolytic streptococci infections (Dekaban, 1968; Hadeed and Siegel, 1989; Leviton et al., 2010; Mostoufi-zadeh et al., 1984) .
Type III interferons (a.k.a. are key antiviral molecules that present an augmented expression during the ZIKV infection in susceptible placental cells (Bayer et al., 2016) . Despite chimeric maternal-fetal properties of placenta, only the maternal component exhibit type III interferon response after ZIKV infection (Weisblum et al., 2017) . Further, single nucleotide polymorphisms (SNPs) in these genes regulate the IFNL1-4 expression and are associated with the outcome of the infectious diseases (O'Brien et al., 2014) . Notably, SNPs in the vicinity of IFN-λ4 are associated with HCV clearance-another member of Flaviviridae family (Suppiah et al., 2009) . Interestingly, the effects of rs12979860 CC genotype have been observed in postpartum normal pregnancy, associated with persistent low level of ISGs IFIT1, IFIT2, IFIT3, and OAS1 (Price et al., 2016) .
In this paper, we describe the association between the genetic background of ZIKVinfected pregnancy and CZS development, focusing on the SNPs located in the region spanning IFNL2 to IFNL4 genes, as well as the functional consequences of specific genotypes for the immunological imbalance in placenta.
RESULTS
Maternal CA/CC genotype of SNP rs8109886 is a protective factor against CZS outcome We used principal component analysis to retrieve 320 SNPs located in the IFNL region which are found among the African and European populations from 1000 Genomes Project ( Figure S1A ); we selected four representative SNPs (rs12979860, rs4803222, rs8109886, and rs8099917) to construct the haplotypes in parental populations. The allele frequencies, annotation, and reference of the selected SNPs are described in Table S1 . The linkage disequilibrium (LD) analysis indicated that, in contrast to the Africans (r2=0.17), SNPs rs12979860 and rs4803222 were in strong LD among the Europeans from 1000 Genomes population (r2 = 0.90) ( Figure S1B ). The arranged haplotypes, tagged by rs12979860 and rs8109886 alleles, have very different frequencies among the Africans and Europeans (Table   S2 ).
The DNA samples from whole blood of 92 ZIKV-infected women, with development of CZS (cases) or otherwise (controls), were genotyped for the SNPs encompassing IFNL4 gene (rs12979860 and rs4803222) and between IFNL2 and IFNL4 genes (rs8099917 and rs8109886). The frequency of each SNP was verified in cases and controls, and the CZS outcome was evaluated. In all the SNPs tested, the genotype frequencies were found in HWE except rs8099917. The data were then adjusted by the trimester of pregnancy-when the symptoms of ZIKV infection were detected-and ancestry (based on genotyping a panel of 46 ancestry informative markers), since we observed differences in haplotype frequencies among the Africans and Europeans (Table S2) . A statistically significant protection was found for the C allele carriers of SNP rs8109886 (OR = 0.22; CI = 0.05-0.91, p = 0.028) (Table 1) . No differences were observed in the frequencies between cases and controls in any other SNPs tested. Since rs12979860 is classically associated with HCV clearance upon IFNα treatment and tag high frequency haplotypes among the Africans and Europeans, we decided to include it in the analysis. Data indicate that an arrangement of rs8109886 C-rs12979860 C is present in 39% of no CZS, whereas only 1.9% has abnormal CZS (OR = 0.07; CI=0.01-0.5, p = 0.003 after co-variate adjustments) (Table S3 ). The clusterization according genotype combination show that CC/CA-CC (rs8109886-rs12979860) combinations resulted in 93% of 'No CZS' cases, (Figure 1 ), while combinations carrying the rs8109886AA genotypes were more frequent among the mothers with CZS children. All the other genotypic analyses included children genotypes or mother:children pairs did not show any significant results (Tables S4 and S5 ). 
Congenital ZIKV infection leads to an immunological imbalance in placenta
To verify functionally how IFNL genotypes would influence ZIKV severe congenital outcomes we performed gene expression analyses from the chimeric fetal-maternal placental tissues, obtained the time of delivery from 10 uninfected pregnant woman and 74 congenital ZIKV cases (Table S6 ). We used a multiplex RT-qPCR analysis of 96 candidate genes, selected based on innate and antiviral immunity and only statistically significant results are presented. First, all the RT-PCR ZIKV positive samples at term showed higher gene expression in most genes analyzed. ZIKV congenital infections occurring at the third trimester of pregnancy resulted in higher gene expression levels. The advanced maternal age mothers expressed lower levels of inflammatory genes, suggesting natural immunological senescence ( Table S7 ). Because of these intrinsic differential expression profile, ZIKV RT-qPCR positive placenta, trimester of exposure to ZIKV, and mothers age greater than or equal to 40 years were considered as confounding variables in gene expression analysis of congenital ZIKV cases.
We observed that placental gene expression from congenital ZIKV infections exhibited an increased expression of IFIT5, IFNA1, IFNB, IFI16, IL22RA, IP10, IRF7, and IRF9, and a decreased expression of TYRO3, when compared with uninfected pregnant women ( Figure   2 ). This result indicates that ZIKV infection leads to a typical inflammatory response in the placenta, including the expression of anti-viral Type I interferon genes (IFIT5, IFNA1, and IFNB), Type II interferon (IFI16), cytokine signaling (IL22RA and IP10), and interferon regulatory factors (IRF7 and IRF9). The number of dots varies according to gene analyzed due to failed amplifications. The median and standard deviation of gene expression values are normalized by the housekeeping genes, selected by the geNorm and NormFinder as well as 18S ribosomal RNA and RLP13 ribosomal protein L13 (grey boxes); values are adjusted by mothers' age (below or equal to/above 40 years old) and infection trimester (the trimester of pregnancy which occurs first Zika symptoms or asymptomatic ZIKV infections) (red lines). Pairwise comparisons of logtransformed (base 2) normalized expression means between/among the groups of interest were performed by contrasts/differences (fold-changes), obtained after both bi-and multivariate linear models modified by ordinary least square regressions. Whenever the variable of interest had more than two levels, p-values were corrected by the Tukey Honest Significant Difference post-Hoc method. After all the gene-per-gene pairwise comparisons were made, we conducted a Type I error adjustment for the multiple comparisons following the Holm-Bonferroni method. P-values ** ≤ 0.01, * ≤ 0.05 and ≤ 0.1.
Interestingly, ZIKV PCR+ placentas showed an increased expression in several Type III interferons as well as Type I interferon genes analyzed, except for IFITM1, which presented reduced expression. Data also demonstrated an augmented expression of CLEC5A
and DCSIGN as well as TLR3 and TLR8 (pattern-recognition) receptors, BCL2, CARD9
(apoptosis-related), IL18 and AIM2 (Type II interferon) and IFNL1 (Type III interferon).
Corroborating the ZIKV-infection pro-inflammatory placental profile, results showed an elevated expression of chemokine-related genes (i.e., CCR2, CCR3, CCR5, MIP1A, and IP10) and other cytokine-related genes (i.e., IL22A, MMP2, and TNF) besides NRPL3, which denotes the presence of inflammasome activation in placenta with ZIKV PCR+ samples.
Results also showed an increase in the expression of IL10 ( Figure S2 ).
Decreased IFNL2 in placenta at term is associated with newborn CNS abnormalities
Next, we tested whether the gene expression signatures of placentas coming from ZIKV-infected women could be associated with the presence or absence of abnormal Central
Nervous System (CNS) formation. These analyses illustrated IFNL2 and ISG15 significant decreases in newborns with CNS alterations, demonstrating that a sustained Type-III IFN genes activation may be required to prevent abnormal CZS. On the other hand, IFIT5 showed a significant increase in newborns with CNS abnormalities group, and given that the results with PCR-positive ZIKV placenta also show increased levels of IFIT5, these data suggest a persistent infection that could be associated with more severe outcomes ( Figure 3 ). Each point corresponds to one placenta analyzed. The number of dots varies according to gene analyzed due to failed amplifications. The median and standard deviation of gene expression values are normalized by the housekeeping genes, selected by the geNorm and NormFinder as well as 18S ribosomal RNA and RLP13 ribosomal protein L13 (grey boxes); values are adjusted by mothers' age (below or equal to/above 40 years old) and infection trimester (the trimester of pregnancy which occurs first Zika symptoms or asymptomatic ZIKV infections) (red lines). Pairwise comparisons of log-transformed (base 2) normalized expression means between/among the groups of interest were performed by contrasts/differences (fold-changes), obtained after both bi-and multivariate linear models modified by ordinary least square regressions. Whenever the variable of interest had more than two levels, pvalues were corrected by the Tukey Honest Significant Difference post-Hoc method. After all the gene-pergene pairwise comparisons were made, we conducted a Type I error adjustment for the multiple comparisons following the Holm-Bonferroni method. P-values ** ≤ 0.01, * ≤ 0.05, and ≤ 0.1.
Rs8109886 genotypes CA/CC in mothers are associated with balanced placental IFIT5 and elevated IFNL3/4 expression
We accessed 30 DNA samples from mothers that had the placenta analyzed, thus placenta gene expression was clustered according to different genotypes (i.e., CA/CC and AA) to validate the case-control analysis of rs8109886. Our data showed that placentas coming from rs8109886 AA mothers showed a significantly increased expression of IFIT5, IFNA1, IL2, MIP1B, MMP2, IL10, IRF7, IRF9, and OAS3 ( Figure S3 ). This result suggests that rs8109886 AA mothers have an exacerbated and uncontrolled cytokine profile, compared with CA/CC mothers. Next, we verified whether placental gene expression in abnormal CZS or no CZS could be modulated by rs8109886 CA/CC and AA genotype. Data
show that CA/CC mothers have a low expression of Type-I IFN ISG IFIT5 and MMP9
besides a visible high expression of IFNL3/4 ( Figure 4A ). Together, these data demonstrate that rs8109886 could act as a modulator for both Type-I IFN and IFNL; mothers with CA/CC genotypes can achieve a balanced response between these two mediators, which are essential to a healthy pregnancy ( Figure 4B ). . Each point corresponds to one placenta analyzed. The number of dots varies according to gene analyzed due to failed amplifications. The median and standard deviation of gene expression values are normalized by the housekeeping genes, selected by the geNorm and NormFinder as well as 18S ribosomal RNA and RLP13 ribosomal protein L13 (grey boxes); values are adjusted by mothers' age (below or equal to/above 40 years old) and infection trimester (the trimester of pregnancy which occurs first Zika symptoms or asymptomatic ZIKV infections) (red lines). Pairwise comparisons of logtransformed (base 2) normalized expression means between/among the groups of interest were performed by contrasts/differences (fold-changes), obtained after both bi-and multivariate linear models modified by ordinary least square regressions. Whenever the variable of interest had more than two levels, p-values were corrected by the Tukey Honest Significant Difference post-Hoc method. After all the gene-per-gene pairwise comparisons were made, we conducted a Type I error adjustment for the multiple comparisons following the Holm-Bonferroni method. P-values **≤ 0.01, * ≤ 0.05, and ≤ 0.1. (c) Schematic representation of the relation between Type I and III IFN in congenital ZIKV infections regarding abnormal CZS, showing that lower risk of developing CZS is related to higher levels of IFNL and balanced levels of Type-I IFN.
DISCUSSION
Despite the high risk, ZIKV infection during pregnancy is necessary, albeit not sufficient, to induce CZS. Here, we conducted a case-control study with CZS cases and healthy ZIKV + mothers. We hypothesized that host genetic background, especially IFNL SNPs, could contribute to CSZ development. IFNL SNPs were described as central in the therapeutic responses to another chronic flavivirus pathogen, Hepatitis C, which is probably one of the most important genetic findings of GWAS era ( Bayer et al., 2016; Price et al., 2006; Suppiah et al., 2009; Tanaka et al., 2009) . Specifically, our results demonstrated that mothers who carried the CA/CC genotypes of SNP rs8109886 (IFNL2-IFNL4) had a 4.5 reduced risk (OR = 0.22) of having children with abnormal CZS, resulting from congenital ZIKV infection, compared with those with AA genotype. One important issue was that ancestry tends to have impacted on the distribution of the major haplotypes studied here; this was done in such a way that we included a panel of AIMs to adjust the potential bias in the recruitment of the cases and controls. After the adjustment of all the co-variates, the association persisted, indicating that there was no recruitment bias and that resistant genotype frequencies between groups were not influenced by ancestry. The rs12979860 has been the most important polymorphism in the region (Eslam et al., 2017) . When, we arranged the haplotypes, including this SNP, our analysis showed that C-C combination at rs8109886 and rs12979860 demonstrated that the likelihood of abnormal CZS was reduced 14.3 times (OR = 0.07). Further, the genotypic combinations confirmed that CA/CC-CC (rs8109886-rs12979860) were strongly protective, while 93% of the mothers did not have CZS. In the same analysis on the fetuses, the results did not suggest any association between the IFNL SNP genotypes and the outcome, despite an OR value indicative of protection in rs8109886 CA/CC individuals.
Following previous clinical studies (Brasil et al., 2016) , in our cohort, the determination of the trimester of pregnancy in which ZIKV infection occurs was a strong predictor factor for CZS outcome. Our findings demonstrated that maternal rs8109886 and rs12979860 genotypes should also be considered as a critical variable for abnormal CZS outcomes prediction ( Figure 5 ). Despite the sample size, which is a limitation that increases uncertainty, it is remarkable that the absence of CZS outcome in mothers that carry the protection-associated genotype combination CC/CA -CC (rs8109886-rs12979860)
considering ZIKV infection in all trimesters of pregnancy in our cohort where the genetic effect is even stronger in the second and third trimester of pregnancy. There was only one fatal case of CZS in a CC/CA -CC mother that developed Zika symptoms in second trimester of pregnancy, characterized by hydrocephalus and arthrogryposis. genotypes, 80% or more of the cases developed CZS, in contrast with second and third trimesters. Considering only rs8109886, this background seems to be associated with protection only for second and third trimester.
For the second trimester, the frequency of CZS was almost five times higher among rs8109886 AA mothers.
For the third trimester, genetic influence seems to be stronger since data shows 75% of CZS in AA against 11% in CC-CA mothers.
IFNL1-4 is mostly expressed by epithelial, plasmocytoid dendritic cells and macrophages (Kotenko and Durbin, 2017; Lazear et al., 2015) , which are cell types presented in placenta. In this sense, our data show that the presence of inflammatory cells in deciduous strongly elicit the IFNL1-4 expression in ZIKV-infected placenta. Notably, placenta from the abnormal CZS cases is associated with an impaired IFNL2 response, accompanied by an uncontrolled and exacerbated Type-I IFN responses; particularly with an increased expression of IFIT5, parallel to a decrease in ISG15 mRNA, which was already identified as being protective of ZIKV ocular manifestations (Singh et al., 2017) . This profile of augmented type I IFN associated with severity is corroborated in ZIKV infected mice model (Yockey et al., 2018) and in other congenital TORCH infections (Racicot et al., 2017; Scott et al., 2012) . In addition, these mothers also had a low Type-I IFN response that characterizes protection; however, it is noteworthy that the studies that involved mice models demonstrated a lack of Type-I IFN response, also leading to CSZ (Miner et al., 2016; Yockey et al., 2018) . Hence, we can hypothesize that a balanced production of Type-I IFN is genetically controlled by higher Type-III IFNs levels; this could, in turn, provide a proper protective response to ZIKV infection in the placenta, which could prevent CZS severe outcomes. Nevertheless, either genetic or functional findings should be independently replicated in other populations.
The PCR ZIKV+ placenta showed increased TLR3 and TLR8 mRNA expressions, which contribute as pattern recognition receptors for ZIKV uptake (Dang et al., 2016; Hamel et al., 2015; Luo et al., 2018; Tiwari et al., 2017) . Although in vitro studies strongly suggest that TYRO3 is the main entry receptor for ZIKV (Bagasra et al., 2017; Hamel et al., 2015) , persistent ZIKV-infected placentas showed a decreased expression of TYRO3 in PCR+ ZIKV individuals, corroborating recent findings in mice indicating that in complex organisms these receptors do not appear to be required for ZIKV infection (Hastings et al., 2017) . Otherwise, increased expressions of CLEC5A and DC-SIGN could also suggest alternative routes for virus uptake or antiviral cellular response, as reported for other flavivirus infections (Chen et al., 2008 (Chen et al., , 2012 Smit et al., 2011; Tassaneetrithep et al., 2003) . A higher expression of BCL2, CARD9, and NRPL3 suggests that ZIKV could lead to apoptosis and activation of inflammasomes in placental cells (Huang et al., 2016; Khaiboullina et al., 2017; Miner et al., 2016; Tricarico et al., 2017) .
In summary, our study showed a novel perspective to understand host-pathogen as determined by standard testing). The infants were evaluated for the following adverse neurologic outcomes: (a) microcephaly (head-circumference z score of less than -2), (b) abnormal brain imaging by pre-or post-natal ultrasound (e.g., computed tomography and/or magnetic resonance imaging), and/or (c) abnormal clinical examination (including neurologic, ocular, and/or auditory with abnormalities confirmed by a multidisciplinary team of neonatologists, neurologists, infectious disease specialists, geneticists, ophthalmologists, and physical therapists). From this cohort, adverse clinical outcomes (mostly neurologic)
have been reported at birth in 46% of infants, and they have been found in infants born to mothers infected during all trimesters. Our study included ZIKV+ pregnant adult women > 18 years of age and their infants. The exclusion criteria were maternal HIV infection and pregnancies complicated by other congenital infections, known to cause infant neurologic damage (e.g., TORCH, CHIKV). Placental samples were collected at the time of delivery and were formalin-fixed, paraffin-embedded (FFPE), and stored in RNA later for posterior RNA extraction. For DNA analysis, pregnant women have 5 mL of blood collected at study enrollment, and for the newborns, an oral swab was collected.
Genetic studies: SNP selection and linkage disequilibrium analysis. The candidate SNPs selection for case-control association study was performed by integrating different tools:
Principal Components Analysis (PCA), ANNOVAR (Wang et al., 2010) , alelle frequencies, literature and HAPLOVIEW (Barrett et al., 2005) . First, all SNPs located in the IFNL region , 2015) . Then, Principal Components Analysis (PCA) was performed using EIGENSOFT4.2 (Barrett et al., 2005) . The use of this strategy in the functional SNPs selection assumes that, since the analyzed variability is of a functional genome region (it means, a gene), the clusters generated by PCA could be mainly influenced by the functionality. Thus, SNPs with high weight for Principal component 1 (PC1) could be a potential candidate for functional role.
So, SNPs were sorted by decreasing the values of "SNP weight" for PC1, and the functional annotation of all the SNPs was performed using ANNOVAR (Wang et al., 2010) , with refGene hg19 (11 Dez 2015) . According to the functional category identified by ANNOVAR, the "SNP weight" for PC1 (with snpweight values among the higher 30, called top SNPs), minimal allele frequencies (MAF) in African and European populations (> 0.1), and associations with infectious diseases already reported in the literature, the SNPs present in the IFNL region were selected for genotyping and haplotype construction. Haplotypes inferences using the selected SNPs, haplotype frequencies, and linkage disequilibrium (LD) analysis for all the studied populations were performed using HAPLOVIEW (Barrett et al., 2005) .
Genomic DNA extraction and SNP genotyping analysis. DNA extraction was performed from saliva swabs or whole blood cells collected from each individual newborn (n=129) and mother (n=92), respectively using the salting out method. After the extraction, the DNA was quantified in a Nanodrop ND 1000 spectrophotometer (Nanodrop Technologies). The following polymorphisms were genotyped. SNPs for IFNL2-IFNL4: rs8099917 (C 11710096_10) located 8.9 kb upstream of the start codon of IFNL4 (T > G) and rs8109886 (C 11710100_10) located 3.3 kb upstream of the start codon of IFNL4 (A > C). IFNL4:
rs12979860 (C 7820464_10) in intron 4 (C > T) and rs4803222 (C 7820457_10) in 5' UTR (C > G). All the SNPs were genotyped using the allelic discrimination method for real-time
TaqMan assays (Applied Biosystems) in the ABI Prism 7000 Sequence Detection System or
Step One Plus Real-time PCR System. About 50 ng of DNA was used in the genotyping reaction. Statistical analyses were performed using packages "snpassoc", "genetics" and "haplo.stats" in software R version 2.11.1, as previously described (2017a). Briefly, genotype frequencies were tested for Hardy-Weinberg equilibrium (HWE) using a Chi-square test.
The genotypic, allelic, and carriers frequencies were calculated and compared in cases and controls by conditional logistic regression adjusted for ancestry and trimester of infection.
Next, we compared the frequencies between CZS and no CZS separately. The values of linkage disequilibrium to SNPs studied in IFNL were estimated by r 2 and the haplotype frequencies were compared between cases and controls by logistic regression also adjusted for ancestry and trimester of infection. For mother-children SNP interaction, we used EMIM analysis using a multinomial model to test the existence (and estimate) of genotype relative risk parameters that may increase (or decrease) the possibility that a child is affected, as described previously (Howey and Cordell, 2012) .
Ancestry analysis. Since Brazilian population is highly heterogeneous and ethnic classification is not uniformly defined, ancestry data is necessary to adjust the logistic regression and eliminate bias in the genetic associations (Barnholtz-Sloan et al., 2008) . Thus, DNA samples were genotyped for 46 AIM-Indels in a multiplex PCR system followed by capillary electrophoresis in ABI 3500 Genetic Analyzer (Thermo Fisher), as described previously (Manta et al., 2013; Pereira et al., 2012) . Allele calls were obtained by GeneMapper v.4.1 and results for individual and global ancestry estimates were performed by using the HGDP-CEPH diversity panel as reference (European, African and Native-american; K=3) in STRUCTURE v2.3. In the logistic regression performed in R, covariates AFR+EUR+AME or AFR+EUR were used to control for population stratification along with trimester of infection. Since both condition resulted in no differences in OR, we choose the EUR+AFR combination because they are the most predominant ancestry in the Brazilian population.
ZIKV PCR detection. RT-PCR was performed using the 2x QuantiTect Probe RT-PCR kit (Qiagen, Valencia, CA, USA) with the same primers and cycle times as previously described (Lanciotti et al., 2008) . All the assays were done in triplicates, and the fluorescence curves that crossed the threshold within or below 38 cycles were considered positive.
Gene expression profile analysis. Analysis of gene expression in placental tissue from pregnant mothers (control, with or without CZS samples) was performed using Fluidigm (Biomark platform) assays. Detailed data available under request. Our experimental design followed a workflow described previously (Guerreiro et al., 2013) .
Real-time RT-PCR expression analysis. From routines created in R language for parsing raw foreground and background intensities, exported from the commercial platform Fluidigm®, we made the background correction and did the exploratory data analysis:
fluorescence accumulation and melting curve graphs of Rn for each reaction in each gene.
For the relative quantification of the expressions, the fluorescence accumulation data of each sample were used for fitting four parameters sigmoid curves using the library qPCR 56 for the R statistical package version 3.4.1(2017a). For each amplification, the cycle of quantification was determined as the maximum of the second derivative of the fit sigmoid curve and the efficiency, as the ratio between the fluorescence of the cycle of quantification and the fluorescence of the cycle that immediately preceded that. For each gene, the estimated efficiency was estimated by the mean of all the efficiencies for each amplification reaction of that gene. Endogenous controls used in normalization between the different amplified samples were selected by the geNorm method. Normalization factors were estimated for each sample using the geometric averaging of the selected normalized genes (Vandesompele et al., 2002) .
Statistical analysis for gene expression. Pairwise comparisons of log-transformed (base 2) normalized expression means between/among groups of interest were performed by contrasts/differences (fold-changes), obtained after both bi-and multivariate linear models modified by ordinary least square regressions. Whenever the variable of interest had more than two levels, p-values were corrected by the Tukey Honest Significant Difference post-Hoc method (WS Cleveland, 1984) . After all the gene-per-gene pairwise comparisons, we conducted a Type I error adjustment for multiple comparisons following the Holm-Bonferroni method (Holm, 1979) . Different sets of confounding variables were selected by clinical experts and included in the multivariate models to adjust the fit effects for different variables of interest for all the genes. For the analysis, two-tailed levels of significance ≤ 0.01, 0.05, and 0.1 were considered as "highly significant," "significant," and "suggestive,"
respectively.
